Neurocrine Biosciences Inc. (NBIX) declined -5.8% or -4.81 to $78.12. It is close to 470526 shares traded, which is 62.63% compare to the average total volume 751314. The market cap of NBIX is $6.97 billion. The year to date change is 4.58%. The 52 week price range is from $39.21 to $92.98. Price of NBIX have changed 1.75% during last week. It have changed -1.78% over last month, 6.88% over last 3 months, 35.33% over last 6 months and 93.17% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NBIX is 85.55. It is 9.51% above current price. The 200-day Moving Averages for NBIX is 66.69. It is -14.63% below current price. The 52-week High is 92.98. It is 19.02% from the current price. The 52-week Low is 39.21. It is -49.81% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of NBIX is 8.27 on 2018-03-15. Short % to float is 7.14%. There are some statistics of NBIX. It is has market cap $6.97 billion. The share outstanding is 89.27 million. The average volume is 751314. The revenue is 161.63M. The gross profit is 160.37M. The percent of top 15 Institution holding is 85.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NBIX is -38.98%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NBIX is -23.10%.